CKO mice developed by SMOC supported the identification of a novel lncRNA that regulates dendritic cell migration and the corresponding immune response


Published on today's Immunity, Prof. Xuetao Cao's group identified a novel long non-coding RNA lnc-Dpf3 whose feedback restrains CCR7-mediated dendritic cell (DC) migration. Mechanistically, CCR7 stimulation activates the HIF-1alpha transcription factor pathway in DCs, leading to metabolic reprogramming towards glycolysis for DC migration. 

SMOC generated lnc-Dpf3fl/flItgax-cre+ mice with conditional deletion of this functional lncRNA in DCs, proving that DC-specific lnc-Dpf3 deficiency selectively promotes CCR7-mediated DC migration. 


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more